2021-01-11,Aptevo Therapeutics Provides Update on Ongoing APVO436 Phase 1 Clinical Trial
2021-01-06,Aptevo Therapeutics Inc. (APVO) Upgraded to Buy: Here's Why
2020-12-19,Kaskela Law LLC Announces Investigation of Aptevo Therapeutics Inc. (APVO) and Encourages Shareholders to Contact the Firm
2020-12-02,Aptevo Therapeutics Announces the Launch of Its Second Platform Technology ADAPTIR-FLEX(TM) and Introduces the New Bispecific Prostate Cancer Candidate APVO442
2020-11-20,"The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger"
2020-11-19,Aptevo Confirms Receipt of Unsolicited Indication of Interest
2020-11-16,Aptevo Therapeutics and Alligator Bioscience Advancing the Bispecific 4-1BBx5T4 Antibody ALG.APV-527 Into Phase 1 Clinical Development
2020-11-10,"The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies"
2020-11-09,Aptevo Therapeutics to Present at the Society for Immunotherapy of Cancer's (SITC) 35th Virtual Annual Meeting
2020-11-09,Aptevo Therapeutics Announces Second Complete Remission in Ongoing APVO436 Phase 1 Clinical Trial
2020-11-08,Aptevo Therapeutics Adopts Limited Duration Stockholder Rights Plan
2020-11-03,Aptevo Therapeutics Announces First Complete Remission in Ongoing APVO436 Phase 1 Clinical Trial
2020-09-01,Aptevo Therapeutics Provides Update on Ongoing APVO436 Phase 1 Clinical Trial
2020-08-14,Aptevo Therapeutics Reports Second Quarter 2020 Financial Results
2020-08-06,Aptevo Therapeutics Secures $25 Million Non-Dilutive Financing from Midcap Financial Trust
2020-07-21,Aptevo Therapeutics Engages Piper Sandler to Sell its RUXIENCE(R) and IXINITY(R) Royalty Streams & Milestones
2020-06-30,All You Need to Know About Aptevo Therapeutics Inc. (APVO) Rating Upgrade to Buy
2020-06-30,Has Aptevo Therapeutics (APVO) Outpaced Other Medical Stocks This Year?
2020-06-29,"Aptevo Therapeutics Collects $750,000 Working Capital Escrow From Medexus Related to IXINITY(R) Sale"
2020-06-25,Aptevo Therapeutics to receive Seven Year Quarterly Royalty Payment Stream from Pfizer for Sales of Rituximab Biosimilar
2020-06-10,Aptevo Therapeutics and Alligator Bioscience Present New Preclinical Data for ALG.APV-527 at the PEGS Virtual Interactive Global Summit
2020-05-13,Aptevo Therapeutics Reports First Quarter 2020 Financial Results
2020-04-14,Aptevo Therapeutics Regains Compliance With Nasdaq Listing Requirements
2020-03-25,Aptevo Therapeutics Reports 2019 Financial Results and Provides Business Update
2020-03-16,Aptevo Therapeutics Provides Update On Ongoing APVO436 Phase 1 Clinical Trial
2020-02-28,Aptevo Therapeutics Sells IXINITY Hemophilia B Therapy for Estimated Proceeds in Excess of $100 Million
2020-02-28,Medexus Expands its US Product Portfolio by Acquiring the Hematology Asset IXINITY®
2020-01-30,Aptevo Therapeutics Doses First Patient in IXINITY Clinical Trial for Potential Pediatric Label Expansion
2020-01-13,Aptevo Therapeutics' APVO436 Selected For Inclusion In The Leukemia & Lymphoma Society's Groundbreaking BEAT AML(R) Master Clinical Trial
2019-12-19,Aptevo Therapeutics Inc. (APVO): Are Hedge Funds Right About This Stock?
2019-12-06,Aptevo Therapeutics Receives Orphan Drug Designation for APVO436 for the Treatment of Acute Myelogenous Leukemia
2019-11-12,What Makes Aptevo Therapeutics Inc. (APVO) a New Buy Stock
2019-11-08,Aptevo Therapeutics and Alligator Bioscience Present New Preclinical Data for ALG.APV-527 at the Society for Immunotherapy of Cancer 2019 Annual Meeting
2019-11-07,Aptevo Therapeutics Reports Third Quarter 2019 Financial Results
2019-10-04,"The Daily Biotech Pulse: Arbutus Halts Hepatitis B Study, Positive Readout For MEI Pharma's Blood Cancer Drug, Ovid Offering"
2019-10-03,Aptevo Therapeutics Provides Corporate and Pipeline Update
2019-10-03,Aptevo Therapeutics Provides Corporate and Pipeline Update
2019-09-19,Aptevo Therapeutics Introduces New Adaptir Bispecific Antibody Candidate Intended for the Treatment of Solid Tumors
2019-08-09,Aptevo Therapeutics Reports Second Quarter 2019 Financial Results
2019-08-07,Aptevo Therapeutics Receives $4.3 Million Milestone Payment From Saol International Limited
2019-07-25,Aptevo Therapeutics Reports Continued Progress In APVO210 and APVO436 Clinical Trials
2019-06-25,Aptevo Therapeutics Launches New 3000 IU IXINITY Assay Offering Enhanced User Experience and Improved Convenience for Hemophilia B Patients
2019-05-09,Aptevo Therapeutics Reports First Quarter 2019 Financial Results
2019-04-29,"The Zacks Analyst Blog Highlights: Advanced Emissions, Aptevo, BankFinancial, Good Times and Health Insurance"
2019-04-26,5 Stocks to Gain From Dollar's Recent Strength
2019-04-15,Aptevo Therapeutics Reports IXINITY® and Pipeline Progress
2019-04-11,What Kind Of Investor Owns Most Of Aptevo Therapeutics Inc. (NASDAQ:APVO)?
2019-04-02,Aptevo Therapeutics Presents New Preclinical Data for APVO436 and ALG.APV-527 at the American Association for Cancer Research 2019 Annual Meeting
2019-03-25,Aptevo Therapeutics to Present New Preclinical Data for APVO436 and ALG.APV.527 at the American Association for Cancer Research 2019 Annual Meeting
2019-03-20,Aptevo Therapeutics Begins Phase 1 Clinical Trial of APVO210 a Novel Bispecific Antibody for the Treatment of Autoimmune and Inflammatory Diseases
2019-03-18,Aptevo Therapeutics Reports 2018 Financial Results and Provides Business Update
2019-03-14,Aptevo Therapeutics Inc. (APVO) Moves to Buy: Rationale Behind the Upgrade
2019-03-07,Aptevo Announces Pricing of $22 Million Offering of Common Stock and Warrants
2019-03-06,Aptevo Announces Proposed Public Offering of Common Stock and Warrants
2019-01-07,Aptevo Therapeutics Highlights Key 2019 Priorities
2019-01-03,Aptevo Therapeutics Collects $3.3 Million In Escrow Funds From Saol Therapeutics
2018-12-21,Aptevo Therapeutics Announces Up To $35 Million Common Stock Purchase Agreement With Lincoln Park Capital
2018-12-20,Need To Know: Aptevo Therapeutics Inc. (NASDAQ:APVO) Insiders Have Been Buying Shares
2018-12-13,Aptevo Therapeutics Doses First Patient in Phase 1/1b Clinical Trial of Lead Next-Generation Bispecific Antibody APVO436
2018-12-11,"United Parcel Service, Endurance International Group, Idera Pharmaceuticals, Aptevo Therapeutics, and Electro Scientific Industries  Future Expectations, Projections Moving into 2018"
2018-11-20,Aptevo Therapeutics to Present at the 30th Annual Piper Jaffray Healthcare Conference
2018-11-14,Aptevo Therapeutics Reports Third Quarter 2018 Financial Results
2018-11-09,Alligator Bioscience and Aptevo Therapeutics Present New Preclinical Data for ALG.APV-527 at the Society for Immunotherapy of Cancer (SITC) 33rd Annual Meeting
2018-10-24,Aptevo Therapeutics Announces Expanded Growth Initiatives for IXINITY
2018-10-10,"Market Trends Toward New Normal in Aptevo Therapeutics, Bottomline Technologies, Allete, Air Lease, The Goodyear Tire & Rubber, and EastGroup Properties  Emerging Consolidated Expectations, Analyst Ratings"
2018-09-25,Aptevo Therapeutics to Present at the Ladenburg Thalmann 2018 Healthcare Conference
2018-09-05,Here's Why Momentum Investors Will Love Aptevo Therapeutics Inc. (APVO)
2018-08-31,Penny Stocks to Buy Using Technical Analysis for September 2018
2018-08-09,Aptevo Therapeutics Reports Second Quarter 2018 Financial Results
2018-08-07,Aptevo Therapeutics Revises Term Loan Agreement With MidCap Financial; Reduces Cash Requirements by $18 Million
2018-08-06,"Report: Developing Opportunities within athenahealth, W.R. Berkley, Air Products and Chemicals, DICK'S Sporting Goods, Aptevo Therapeutics, and Columbia Property Trust  Future Expectations, Projections Moving into 2018"
2018-05-29,Novel First-In-Class Immunotherapeutic APVO210 Features Unique Mechanism of Action Delivering IL-10
2018-05-15,Wired News  Arrowhead Pharma Presented Preclinical Data on Expanding Pipeline of RNAi Therapeutics for Cardiometabolic Diseases
2018-05-10,Aptevo Therapeutics Reports First Quarter 2018 Financial Results
2018-05-08,New Preclinical Data for Novel Immunotherapy Bispecific Candidate ALG.APV-527 Presented by Aptevo Therapeutics and Alligator Bioscience at Prominent Industry Conferences
2018-05-01,Aptevo Therapeutics Announces IND Submission for APVO436
2018-04-30,"Report: Developing Opportunities within Natus Medical, Aptevo Therapeutics, Revlon, Silgan, Resources Connection, and TrustCo Bank Corp NY  Future Expectations, Projections Moving into 2018"
2018-04-20,Aptevo executive Jane Gross jumped to a startup and landed in the C-Suite
2018-04-16,Aptevo Therapeutics Bispecific Antibody APVO436 Shows Robust T-Cell Activation With Minimal Cytokine Release
2018-03-19,"Research Report Identifies Ambarella, Merit Medical, NETGEAR, Independent Bank, Cutera, and Aptevo Therapeutics with Renewed Outlook  Fundamental Analysis, Calculating Forward Movement"
2018-03-13,Aptevo Therapeutics Reports 2017 Financial Results and Provides Business Update
2018-03-12,Aptevo Therapeutics Presents New Patient-Reported Data With IXINITY
2018-02-27,Aptevo Therapeutics to Present at the 30th Annual ROTH Conference
2018-01-17,"Report: Exploring Fundamental Drivers Behind Anthera Pharmaceuticals, Alarm, Aptevo Therapeutics, Shoe Carnival, Independent Bank, and First Internet  New Horizons, Emerging Trends, and Upcoming Developments"
2018-01-11,How Is Bioverativs Alprolix Positioned Now?
2018-01-08,Aptevo Therapeutics Begins Patient Dosing in Phase 2 Clinical Trial of Otlertuzumab in Peripheral T-Cell Lymphoma
2018-01-03,"Aptevo Therapeutics, Inc. :APVO-US: Earnings Analysis: Q3, 2017 By the Numbers : January 3, 2018"
2017-12-27,"ETFs with exposure to Aptevo Therapeutics, Inc. : December 27, 2017"
2017-12-19,Does Aptevo Therapeutics Incs (NASDAQ:APVO) 74.9% EPS Growth Reflect The Long-Term Trend?
2017-12-11,"ETFs with exposure to Aptevo Therapeutics, Inc. : December 11, 2017"
2017-12-11,Aptevo Therapeutics Novel Bispecific Antibody Therapeutic APVO436 Shows Broad Activity in Primary Human AML Samples
2017-11-29,"ETFs with exposure to Aptevo Therapeutics, Inc. : November 29, 2017"
2017-11-28,Aptevo Therapeutics Announces Plans to Conduct Phase 2 Study of Otlertuzumab in Peripheral T-Cell Lymphoma
2017-11-21,Is Aptevo Therapeutics Incs (APVO) Balance Sheet Strong Enough To Weather A Storm?
2017-11-14,Aptevo Therapeutics to Present at the 29th Annual Piper Jaffray Healthcare Conference
2017-11-09,Aptevo Therapeutics Reports Third Quarter 2017 Financial Results
2017-11-01,"ETFs with exposure to Aptevo Therapeutics, Inc. : November 1, 2017"
2017-10-30,Aptevo Therapeutics Presents New Preclinical Data on APVO436  a Next Generation ADAPTIR Bispecific Antibody Candidate
2017-10-24,Tumor Antigen 5T4 Associated With Many Forms of Solid Tumors Identified as the Second Target for ALG.APV-527  a Novel Bispecific Antibody Candidate Being Developed by Alligator Bioscience and Aptevo Therapeutics
2017-10-16,Aptevo Therapeutics Showcases New Mechanism of Action for Its ADAPTIR Platform at the Inflammation Research Society Meeting
